骨髓性肉瘤具有高频率的激活MAPK/ERK通路的突变,并与克隆性造血有关
Dominik Nann1, Tim-Colin Schade1, Mathis Overkamp1
1Institute of Pathology and Neuropathology, University Hospital Tuebingen and Comprehensive Cancer Center South West, Tuebingen, Germany.
The journal of pathology. Clinical research
|September 4, 2025
概括
骨髓性肉瘤 (MS) 经常显示MAPK/ ERK路径突变和激活. 在老年患者中,基因分析显示了克隆进化和与克隆造血的相关性.
科学领域:
- 血液学
- 癌症学
- 分子生物学
背景情况:
- 骨髓性瘤 (MS) 是骨髓细胞爆发的外骨瘤.
- 关于多发性硬化,特别是新发病例的遗传数据有限.
- 了解多发性硬化遗传学对于诊断和治疗至关重要.
研究的目的:
- 调查骨髓性肉瘤的遗传情况.
- 确定MS发展中的常见突变和途径.
- 将多发性硬化症的遗传特征与先前的骨髓瘤和克隆性血液形成进行比较.
主要方法:
- 针对41个成员国的样本进行下一代测序 (NGS).
- 基于RNA的融合检测和基因表达概况 (GEP).
- 移植前和移植后骨髓活检的分析.
主要成果:
- 最常发生突变的基因是TET2,NPM1和NRAS.
- 74% 的多发性硬化病例在MAPK/ ERK路径中发生突变.
- 与之前的骨髓瘤和克隆造血相比,MS 呈现出明显的遗传变化.
结论:
- 骨髓性肉瘤的特征是经常发生MAPK/ ERK通路的改变.
- 在MS中观察到克隆进化和与克隆造血相关性.
- 基因分析有助于理解多发性硬化病变和患者分层.
相关概念视频
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K


